Therapie der physischen Frailty

Frailty beschreibt als ein übergeordnetes geriatrisches Syndrom ein potenziell reversibles Übergangsstadium zwischen funktioneller Autonomie und irreversibler Hilfsbedürftigkeit. Frailty adressiert damit ein „Window of Opportunity“, in dem funktionelle Einschränkungen mit Erfolg therapiert werden können. Der vorliegende Beitrag gibt einen Überblick über aktuelle Therapieansätze und ihre wissenschaftliche Evidenz.

Abstract

As an overarching geriatric syndrome, frailty describes a potentially reversible transitional stage between functional autonomy and irreversible disability. Thus, frailty addresses a “window of opportunity” in which functional limitations can be successfully treated. This article provides an overview of the therapeutic approaches and their scientific evidence.

Kernaussagen

• Ziele der Frailty-Therapie sind die Verbesserung der funktionellen Autonomie und der Lebensqualität.

• Die „First-Line-Therapie“ ist ein körperliches Mehrkomponententraining, bestehend aus Kraftübungen, kombiniert mit anderen Trainingsmodalitäten (Balance, Ausdauer, funktionelles Training).

• Die allgemeinen Empfehlungen der WHO zur körperlichen Aktivität gelten auch für ältere Personen mit Frailty: 150 Minuten pro Woche mit moderater Intensität.

• Bei Vorliegen einer Protein-Energie-Malnutrition sollte die Trainingstherapie zwingend mit einer Ernährungstherapie kombiniert werden.

• Die Therapie beteiligter Komorbiditäten und ein (Multi-)Medikationscheck mit Blick auf sturz- oder delirfördernde Arzneimittel sollten fester Bestandteil der Therapie sein.

Schlüsselwörter

Frailty - Training - Ernährung

Keywords

frailty - training - nutrition

Publikationsverlauf

Artikel online veröffentlicht:
29. Dezember 2023

• Literatur

• 1 Dent E, Lien C, Lim WS. et al. The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty. J Am Med Dir Assoc 2017; 18: 564-575
• 2 Dent E, Morley JE, Cruz-Jentoft AJ. et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. J Nutr Health Aging 2019; 23: 771-787
• 3 Izquierdo M, Merchant RA, Morley JE. et al. International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. J Nutr Health Aging 2021; 25: 824-853
• 4 Zhao W, Hu P, Sun W. et al. Effect of physical activity on the risk of frailty: A systematic review and meta-analysis. PLoS One 2022; 17: e0278226
• 5 Papiol M, Serra-Prat M, Vico J. et al. Poor muscle strength and low physical activity are the most prevalent frailty components in community-dwelling older adults. J Aging Phys Act 2016; 24: 363-368
• 6 Angulo J, El Assar M, Álvarez-Bustos A. et al. Physical activity and exercise: Strategies to manage frailty. Redox Biol 2020; 35: 101513
• 7 Negm AM, Kennedy CC, Thabane L. et al. Management of frailty: A systematic review and network meta-analysis of randomized controlled trials. J Am Med Dir Assoc 2019; 20: 1190-1198
• 8 Sun X, Liu W, Gao Y. et al. Comparative effectiveness of non-pharmacological interventions for frailty: a systematic review and network meta-analysis. Age Ageing 2023; 52: afad004
• 9 Cadore EL, Rodríguez-Mañas L, Sinclair A. et al. Effects of different exercise interventions on risk of falls, gait ability, and balance in physically frail older adults: a systematic review. Rejuvenation Res 2013; 16: 105-114
• 10 de Labra C, Guimaraes-Pinheiro C, Maseda A. et al. Effects of physical exercise interventions in frail older adults: a systematic review of randomized controlled trials. BMC Geriatr 2015; 15: 154
• 11 Lau LK, Tou NX, Jabbar KA. et al. The effects of exercise interventions on physical performance and activities of daily living in oldest-old and frail older adults: a review of the literature. Am J Phys Med Rehabil 2023; 102: 939-949
• 12 Zhang Y, Zhang Y, Du S. et al. Exercise interventions for improving physical function, daily living activities and quality of life in community-dwelling frail older adults: A systematic review and meta-analysis of randomized controlled trials. Geriatr Nurs 2020; 41: 261-273
• 13 Ligthart-Melis GC, Luiking YC, Kakourou A. et al. Frailty, sarcopenia, and malnutrition frequently (co-)occur in hospitalized older adults: a systematic review and meta-analysis. J Am Med Dir Assoc 2020; 21: 1216-1228
• 14 Petermann-Rocha F, Pell JP, Celis-Morales C. et al. Frailty, sarcopenia, cachexia and malnutrition as comorbid conditions and their associations with mortality: a prospective study from UK Biobank. J Public Health (Oxf) 2022; 44: e172-e180
• 15 Goodpaster BH, Park SW, Harris TB. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61: 1059-1064
• 16 Rus GE, Porter J, Brunton A. et al. Nutrition interventions implemented in hospital to lower risk of sarcopenia in older adults: A systematic review of randomised controlled trials. Nutr Diet 2020; 77: 90-102
• 17 Volkert D, Beck AM, Cederholm T. et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 2019; 38: 10-47
• 18 O‘Connor D, Molloy AM, Laird E. et al. Sustaining an ageing population: the role of micronutrients in frailty and cognitive impairment. Proc Nutr Soc 2023; 82: 315-328
• 19 Ling Y, Xu F, Xia X. et al. Vitamin D supplementation reduces the risk of fall in the vitamin D deficient elderly: An updated meta-analysis. Clin Nutr 2021; 40: 5531-5537
• 20 Bauer J, Biolo G, Cederholm T. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013; 14: 542-559
• 21 Schuetz P, Fehr R, Baechli V. et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet 2019; 393: 2312-2321
• 22 Baumgartner A, Pachnis D, Parra L. et al. The impact of nutritional support on malnourished inpatients with aging-related vulnerability. Nutrition 2021; 89: 111279
• 23 Cesari M, Bernabei R, Vellas B. et al. Challenges in the development of drugs for sarcopenia and frailty – report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force. J Frailty Aging 2022; 11: 135-142
• 24 Pazan F, Petrovic M, Cherubini A. et al. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials. Eur J Clin Pharmacol 2021; 77: 1-12
• 25 Gnjidic D, Hilmer SN, Blyth FM. et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012; 91: 521-528
• 26 Rennie KJ, Witham M, Bradley P. et al. MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty – protocol for a double-blind, randomised controlled proof-of-concept trial. BMJ Open 2022; 12: e061823
• 27 Muhlbauer V, Dallmeier D, Brefka S. et al. The pharmacological treatment of arterial hypertension in frail, older patients – a systematic review. Dtsch Arztebl Int 2019; 116: 23-30
• 28 Bollig C, Torbahn G, Bauer J. et al. Evidence gap on antihyperglycemic pharmacotherapy in frail older adults : A systematic review. Z Gerontol Geriatr 2021; 54: 278-284
• 29 Fairhall N, Aggar C, Kurrle SE. et al. Frailty Intervention Trial (FIT). BMC Geriatrics 2008; 8: 27
• 30 Werner C, Wolf-Belala N, Nerz C. et al. A multifactorial interdisciplinary intervention to prevent functional and mobility decline for more participation in (pre-)frail community-dwelling older adults (PromeTheus): study protocol for a multicenter randomized controlled trial. BMC Geriatrics 2022; 22: 124